MKS Options Traders Turn Defensive Before Q3 Print

MKS Inc. reports Q3 results on November 4 with options positioning flashing the most pronounced defensive tilt seen in months, even as the lending market shows no sign of structural short pressure.

The clearest signal into the print is in options. The put/call ratio jumped to 0.43 on November 2, more than four standard deviations above its 20-day average of 0.21. That is a sharp one-day shift: the ratio had been running below 0.20 for most of October before the spike. The 52-week range runs from 0.11 to 1.17, so the current reading sits in the upper portion of what has been a broadly call-heavy tape. The stock is down 2.7% on Monday and 29.6% over the past month, closing at $196.54, a steep decline that has arrived at a time when its closest peers have also weakened. Lam Research fell 4.2% on the week, Applied Materials dropped 3.4%, and Teradyne shed more than 15%.

Short interest at 7.4% of the free float is a meaningful position, but it has moved in the opposite direction from the options shift. Shares short fell nearly 20% over the past month, from roughly 6.2 million to just under 5.0 million, a significant cover. Borrow availability has actually loosened over the same period, now at 2,054% with plenty of shares on offer relative to what is already borrowed, the highest availability reading in over a year against a 52-week low of 536%. Cost to borrow remains minimal at 0.49%, up modestly on the week but well within the cheap range. Taken together, those lending metrics tell a story of short sellers retreating, not piling in.

The debate around the print centres on whether Q2's momentum can hold. The bull case rests on a strong base: Q2 revenue rose 28% to $1.25 billion, adjusted EBITDA climbed 49%, and management guided Q3 semiconductor growth above 50% year over year, supported by AI-related demand in the Electronics and Packaging segment. Morgan Stanley, maintaining its Overweight rating, trimmed its price target to $330 from $345 on October 26, while the broader analyst consensus clusters around $407. The gap between that consensus target and the current $196.54 price is wide enough to suggest either the consensus is lagging the stock's sharp decline or analysts are expecting a recovery. Bears point to more immediate concerns: free cash flow dropped to $29 million in Q2 from $91 million in Q4, working capital needs are rising, and $4 billion in net debt at 3.0x leverage leaves the balance sheet sensitive to any revenue shortfall from WFE cycle weakness or component sourcing disruptions.

One data point worth noting from ORTEX is the Wikipedia attention signal, which registered a z-score of 4.95 against MKSI's own 90-day history as of October 19, the highest retail attention reading in that period. That is a measure of interest, not a revenue indicator, but it coincides with the options spike and suggests the upcoming print has drawn unusually broad attention. The earnings report will test whether MKS can sustain its semiconductor equipment growth trajectory while demonstrating that the Q2 free cash flow decline was temporary rather than a structural shift in its deleveraging story.